Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.70 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.69 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.69 |
| ▸ | MAPT | P10636 | 2/20 | 0.67 |
| ▸ | BLM | P54132 | 1/20 | 0.67 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.58 |
| ▸ | ACHE | P22303 | 3/20 | 0.57 |
| ▸ | RAD52 | P43351 | 1/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.55 |
| ▸ | FABP3 | P05413 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | PAM | P19021 | 2/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | NR5A2 | O00482 | 1/20 | 0.52 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.52 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.52 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.52 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.52 |
| ▸ | PGR | P06401 | 1/20 | 0.52 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6829812 | 0.98 | DGKA (0.74) | DGKAADRA2AADRA1AMAPTBLM | |
| SCHEMBL8385120 | 0.98 | DGKA (0.74) | DGKAADRA2AADRA1AMAPTBLM | |
| SCHEMBL198091 | 0.98 | DGKA (0.74) | DGKAADRA2AADRA1AMAPTBLM | |
| Hydrochloric Acid SCHEMBL5316150 | 0.98 | MAPT (0.70) | DGKAADRA2AADRA1AMAPTBLM | |
| SCHEMBL8383254 | 0.98 | DGKA (0.74) | DGKAADRA2AADRA1AMAPTBLM | |
| SCHEMBL200400 | 0.98 | DGKA (0.74) | DGKAADRA2AADRA1AMAPTBLM | |
| SCHEMBL8385098 | 0.98 | DGKA (0.74) | DGKAADRA2AADRA1AMAPTBLM | |
| SCHEMBL8855865 | 0.98 | DGKA (0.74) | DGKAADRA2AADRA1AMAPTBLM | |
| SCHEMBL153530 | 0.98 | DGKA (0.74) | DGKAADRA2AADRA1AMAPTBLM | |
| SCHEMBL8385105 | 0.98 | DGKA (0.74) | DGKAADRA2AADRA1AMAPTBLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 103 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260115140-A1 | COMPOSITIONS FOR ENHANCED MUCOSAL PENETRATION | SHIN NIPPON BIOMEDICAL LABORATORIES LTD (JP) | 2026-04-30 | — | — | US | claimed |
| EP-4719476-A1 | COMPOSITIONS FOR ENHANCED MUCOSAL PENETRATION | Shin Nippon Biomedical Laboratories, Ltd. (JP) | 2026-04-08 | — | — | EP | claimed |
| WO-2024246607-A1 | COMPOSITIONS FOR ENHANCED MUCOSAL PENETRATION | SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. (JP) | 2024-12-05 | — | — | WO | claimed |
| CN-118058284-A | Fatty acid choline salt soluble solution and preparation method and application thereof | 郑州郑氏化工产品有限公司 | 2024-05-24 | — | — | CN | claimed |
| CN-116407605-A | Preparation for improving blood and lymph circulation and preparation method thereof | 山东信美生物科技有限公司 | 2023-07-11 | — | — | CN | claimed |
| US-10143969-B2 | Compounds for the capture of carbon dioxide from gaseous mixtures and subsequent release, related process and plant | UNIVERSITA DEGLI STUDI DI MILANO-BICOCCA (IT) | 2018-12-04 | — | — | US | claimed |
| CN-106581481-A | Medicine composition capable of combining with chemotherapy for treating malignant lymphoma, and preparation method thereof | 济南昊雨青田医药技术有限公司 | 2017-04-26 | — | — | CN | claimed |
| US-20160346734-A1 | NOVEL COMPOUNDS FOR THE CAPTURE OF CARBON DIOXIDE FROM GASEOUS MIXTURES AND SUBSEQUENT RELEASE, RELATED PROCESS AND PLANT | UNIVERSITA DEGLI STUDI DI MILANO-BICOCCA (IT) | 2016-12-01 | — | — | US | claimed |
| EP-3094399-A2 | NOVEL COMPOUNDS FOR THE CAPTURE OF CARBON DIOXIDE FROM GASEOUS MIXTURES AND SUBSEQUENT RELEASE, RELATED PROCESS AND PLANT | Università Degli Studi Di Milano - Bicocca (IT) | 2016-11-23 | — | — | EP | claimed |
| EP-0206947-B1 | PHARMACEUTICAL COMPOSITION CONTAINING CHOLINE ESTER SALTS FOR ENHANCING GASTROINTESTINAL TRACT ABSORPTION | MERCK & CO. INC. (US) | 1992-04-15 | — | — | EP | claimed |
| EP-0214898-B1 | CHOLINE ESTERS AS ABSORPTION-ENHANCING AGENTS FOR DRUG DELIVERY THROUGH MUCOUS MEMBRANES OF THE NASAL, BUCCAL, SUBLINGUAL AND VAGINAL CAVITIES | MERCK & CO. INC. (US) | 1992-03-11 | — | — | EP | claimed |
| US-4973579-A | VIRICIDES | MERCK & CO., INC. (US) | 1990-11-27 | — | — | US | claimed |
| US-4963556-A | ANTIVIRAL AGENTS | MERCK & CO., INC. (US) | 1990-10-16 | — | — | US | claimed |
| US-4835138-A | Choline esters as absorption-enhancing agents for drug delivery through mucous membranes of the nasal, buccal, sublingual and vaginal cavities | MERCK & CO., INC. (US) | 1989-05-30 | — | — | US | claimed |
| US-4822773-A | Enhancement of absorption of drugs from gastrointestinal tract using choline ester salts | MERCK & CO., INC. (US) | 1989-04-18 | — | — | US | claimed |
| US-4729989-A | Enhancement of absorption of drugs from gastrointestinal tract using choline ester salts | MERCK & CO., INC. (US) | 1988-03-08 | — | — | US | claimed |
| US-4692441-A | B-LACTAM ANTIBIOTICS | MERCK & CO., INC. (US) | 1987-09-08 | — | — | US | claimed |
| EP-0214898-A2 | Choline esters as absorption-enhancing agents for drug delivery through mucous membranes of the nasal, buccal, sublingual and vaginal cavities | MERCK & CO. INC. (US) | 1987-03-18 | — | — | EP | claimed |
| EP-0206947-A2 | Pharmaceutical composition containing choline ester salts for enhancing gastrointestinal tract absorption | MERCK & CO. INC. (US) | 1986-12-30 | — | — | EP | claimed |
| US-20260115140-A1 | COMPOSITIONS FOR ENHANCED MUCOSAL PENETRATION | SHIN NIPPON BIOMEDICAL LABORATORIES LTD (JP) | 2026-04-30 | — | — | US | disclosed |
| EP-4719476-A1 | COMPOSITIONS FOR ENHANCED MUCOSAL PENETRATION | Shin Nippon Biomedical Laboratories, Ltd. (JP) | 2026-04-08 | — | — | EP | disclosed |
| US-20260034075-A1 | CHOLINE CARBOXYLIC ACID BASED IONIC LIQUIDS AS ANTIMICROBIAL AGENTS | UNIV MISSISSIPPI (US) | 2026-02-05 | — | — | US | disclosed |
| US-20250354930-A1 | IONIC LIQUID ENCAPSULATION OF NIR DYES FOR THE IMPROVEMENT OF BLOODSTAIN DETECTION | UNIV MISSISSIPPI (US) | 2025-11-20 | — | — | US | disclosed |
| US-12440438-B2 | Method of remotely controlling pain | Novilla Pharmaceuticals, Inc. (US) | 2025-10-14 | — | — | US | disclosed |
| EP-3503927-B1 | TOPICAL FORMULATIONS BASED ON IONIC SPECIES FOR SKIN TREATMENT | UNIV CALIFORNIA (US) | 2025-02-19 | — | — | EP | disclosed |
| WO-2024246607-A1 | COMPOSITIONS FOR ENHANCED MUCOSAL PENETRATION | SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. (JP) | 2024-12-05 | — | — | WO | disclosed |
| CN-118058284-A | Fatty acid choline salt soluble solution and preparation method and application thereof | 郑州郑氏化工产品有限公司 | 2024-05-24 | — | — | CN | disclosed |
| US-20240156964-A1 | IONIC LIQUIDS FOR TRANSDERMAL DRUG DELIVERY | THE ARIZONA BOARD OF REGENTS | 2024-05-16 | — | — | US | disclosed |
| WO-2024044526-A1 | RED BLOOD CELL-HITCHHIKING IONIC LIQUID COATED NANOPARTICLES FOR CROSSING THE BLOOD BRAIN BARRIER | UNIVERSITY OF MISSISSIPPI (US) | 2024-02-29 | — | — | WO | disclosed |
| WO-2024030844-A1 | CHOLINE CARBOXYLIC ACID BASED IONIC LIQUIDS AS ANTIMICROBIAL AGENTS | UNIVERSITY OF MISSISSIPPI (US) | 2024-02-08 | — | — | WO | disclosed |
| US-11786597-B2 | Ionic liquids for transdermal drug delivery | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-10-17 | — | — | US | disclosed |
| US-20230310528-A1 | DEEP EUTECTIC SOLVENT INCLUDING ONE OR MORE ACTIVE PHARMACEUTICAL INGREDIENTS DERIVED FROM MUSHROOMS | OPTIMI HEALTH CORP (CA) | 2023-10-05 | — | — | US | disclosed |
| CN-116407605-A | Preparation for improving blood and lymph circulation and preparation method thereof | 山东信美生物科技有限公司 | 2023-07-11 | — | — | CN | disclosed |
| CN-116407605-A | Preparation for improving blood and lymph circulation and preparation method thereof | 山东信美生物科技有限公司 | 2023-07-11 | — | — | CN | disclosed |
| US-20230093875-A1 | IONIC LIQUIDS FOR INTERNAL DELIVERY | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2023-03-30 | — | — | US | disclosed |
| US-20230040805-A1 | IONIC LIQUIDS FOR INTERNAL DELIVERY | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2023-02-09 | — | — | US | disclosed |
| US-11446253-B2 | Ionic liquids for internal delivery | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2022-09-20 | — | — | US | disclosed |
| US-20220257767-A1 | IONIC LIQUIDS FOR DRUG DELIVERY | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2022-08-18 | — | — | US | disclosed |
| EP-3946261-A1 | IONIC LIQUIDS FOR DRUG DELIVERY | President And Fellows Of Harvard College (US) | 2022-02-09 | — | — | EP | disclosed |
| EP-3062819-B1 | IONIC LIQUIDS FOR TRANSDERMAL DRUG DELIVERY | UNIV CALIFORNIA (US) | 2021-12-22 | — | — | EP | disclosed |
| US-20210380929-A1 | METHODS, APPARATUS AND KITS FOR BACTERIAL CELL LYSIS | TECHNISCHE UNIVERSITÄT WIEN (AT) | 2021-12-09 | — | — | US | disclosed |
| US-20210380930-A1 | METHODS, APPARATUS AND KITS FOR BACTERIAL CELL LYSIS | TECHNISCHE UNIVERSITÄT WIEN (AT) | 2021-12-09 | — | — | US | disclosed |
| EP-3877542-A1 | METHODS, APPARATUS AND KITS FOR BACTERIAL CELL LYSIS | Technische Universität Wien (AT) | 2021-09-15 | — | — | EP | disclosed |
| EP-3877505-A1 | METHODS, APPARATUS AND KITS FOR BACTERIAL CELL LYSIS | Technische Universität Wien (AT) | 2021-09-15 | — | — | EP | disclosed |
| US-20210162050-A1 | TOPICAL FORMULATIONS BASED ON IONIC SPECIES FOR SKIN TREATMENT | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2021-06-03 | — | — | US | disclosed |
| US-10912834-B2 | Topical formulations based on ionic species for skin treatment | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2021-02-09 | — | — | US | disclosed |
| US-20210022993-A1 | METHOD OF REMOTELY CONTROLLING PAIN | Novilla Pharmaceuticals, Inc. | 2021-01-28 | — | — | US | disclosed |
| US-20210023009-A1 | NANO-SIZED PARTICLES COMPRISING MULTI-HEADED AMPHIPHILES FOR TARGETED DRUG DELIVERY | BEN GURION UNIV OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY (IL) | 2021-01-28 | — | — | US | disclosed |
| WO-2021016236-A1 | METHOD OF REMOTELY CONTROLLING PAIN | Novilla Pharmaceuticals, Inc. (US) | 2021-01-28 | — | — | WO | disclosed |
| US-10842747-B2 | Nano-sized particles comprising multi-headed amphiphiles for targeted drug delivery | Ben-Gurion University of Negev R & D (IL) | 2020-11-24 | — | — | US | disclosed |
| WO-2020205409-A1 | IONIC LIQUIDS FOR DRUG DELIVERY | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2020-10-08 | — | — | WO | disclosed |
| EP-3709974-A1 | IONIC LIQUIDS FOR INTERNAL DELIVERY | President And Fellows Of Harvard College (US) | 2020-09-23 | — | — | EP | disclosed |
| US-20200289421-A1 | IONIC LIQUIDS FOR INTERNAL DELIVERY | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2020-09-17 | — | — | US | disclosed |
| EP-3650532-A1 | METHODS, APPARATUS AND KITS FOR BACTERIAL CELL LYSIS | Technische Universität Wien (AT) | 2020-05-13 | — | — | EP | disclosed |
| EP-3650554-A1 | METHODS, APPARATUS AND KITS FOR BACTERIAL CELL LYSIS | Technische Universität Wien (AT) | 2020-05-13 | — | — | EP | disclosed |
| US-10449254-B2 | Ionic liquids for transdermal drug delivery | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2019-10-22 | — | — | US | disclosed |
| EP-3539535-A1 | NANO-SIZED PARTICLES COMPRISING MULTI-HEADED AMPHIPHILES FOR TARGETED DRUG DELIVERY | Ben-Gurion University of The Negev Research and Development Authority (IL) | 2019-09-18 | — | — | EP | disclosed |
| WO-2019099837-A9 | IONIC LIQUIDS FOR INTERNAL DELIVERY | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2019-09-12 | — | — | WO | disclosed |
| CN-110101811-A | A kind of integration of drinking and medicinal herbs improves the Chinese herbal medicine formula of animal products quality | 驻马店市久久农牧科技有限公司 | 2019-08-09 | — | — | CN | disclosed |
| EP-3503927-A1 | TOPICAL FORMULATIONS BASED ON IONIC SPECIES FOR SKIN TREATMENT | The Regents of the University of California (US) | 2019-07-03 | — | — | EP | disclosed |
| US-20190192661-A1 | TOPICAL FORMULATIONS BASED ON IONIC SPECIES FOR SKIN TREATMENT | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2019-06-27 | — | — | US | disclosed |
| CN-109789216-A | Skin treating topical formulations based on ionic species | 加利福尼亚大学董事会 | 2019-05-21 | — | — | CN | disclosed |
| US-10143969-B2 | Compounds for the capture of carbon dioxide from gaseous mixtures and subsequent release, related process and plant | UNIVERSITA DEGLI STUDI DI MILANO-BICOCCA (IT) | 2018-12-04 | — | — | US | disclosed |
| US-10143969-B2 | Compounds for the capture of carbon dioxide from gaseous mixtures and subsequent release, related process and plant | UNIVERSITA DEGLI STUDI DI MILANO-BICOCCA (IT) | 2018-12-04 | — | — | US | disclosed |
| EP-2427175-B1 | NANO-SIZED PARTICLES COMPRISING MULTI-HEADED AMPHIPHILES FOR TARGETED DRUG DELIVERY | BEN GURION UNIV OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY (IL) | 2018-08-29 | — | — | EP | disclosed |
| CN-107922719-A | For unsaturated polyester resin and the antistatic bicomponent agent of epoxy vinyl ester resin | 阿万扎雷创新科技有限公司 | 2018-04-17 | — | — | CN | disclosed |
| WO-2018044920-A1 | TOPICAL FORMULATIONS BASED ON IONIC SPECIES FOR SKIN TREATMENT | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2018-03-08 | — | — | WO | disclosed |
| US-20170367980-A1 | NANO-SIZED PARTICLES COMPRISING MULTI-HEADED AMPHIPHILES FOR TARGETED DRUG DELIVERY | C/O BEN-GURION UNIV OF THE NEGEV R & D (IL) | 2017-12-28 | — | — | US | disclosed |
| US-9642803-B2 | Nano-sized particles comprising multi-headed amphiphiles for targeted drug delivery | BEN-GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY (IL) | 2017-05-09 | — | — | US | disclosed |
| CN-106581481-A | Medicine composition capable of combining with chemotherapy for treating malignant lymphoma, and preparation method thereof | 济南昊雨青田医药技术有限公司 | 2017-04-26 | — | — | CN | disclosed |
| US-20160346734-A1 | NOVEL COMPOUNDS FOR THE CAPTURE OF CARBON DIOXIDE FROM GASEOUS MIXTURES AND SUBSEQUENT RELEASE, RELATED PROCESS AND PLANT | UNIVERSITA DEGLI STUDI DI MILANO-BICOCCA (IT) | 2016-12-01 | — | — | US | disclosed |
| US-20160346734-A1 | NOVEL COMPOUNDS FOR THE CAPTURE OF CARBON DIOXIDE FROM GASEOUS MIXTURES AND SUBSEQUENT RELEASE, RELATED PROCESS AND PLANT | UNIVERSITA DEGLI STUDI DI MILANO-BICOCCA (IT) | 2016-12-01 | — | — | US | disclosed |
| EP-3094399-A2 | NOVEL COMPOUNDS FOR THE CAPTURE OF CARBON DIOXIDE FROM GASEOUS MIXTURES AND SUBSEQUENT RELEASE, RELATED PROCESS AND PLANT | Università Degli Studi Di Milano - Bicocca (IT) | 2016-11-23 | — | — | EP | disclosed |
| US-20160263225-A1 | IONIC LIQUIDS FOR TRANSDERMAL DRUG DELIVERY | THE ARIZONA BOARD OF REGENTS | 2016-09-15 | — | — | US | disclosed |
| EP-3062819-A2 | IONIC LIQUIDS FOR TRANSDERMAL DRUG DELIVERY | The Regents of The University of California (US) | 2016-09-07 | — | — | EP | disclosed |
| WO-2015107416-A3 | NOVEL COMPOUNDS FOR THE CAPTURE OF CARBON DIOXIDE FROM GASEOUS MIXTURES AND SUBSEQUENT RELEASE, RELATED PROCESS AND PLANT | UNIVERSITA DEGLI STUDI DI MILANO-BICOCCA (IT) | 2015-12-10 | — | — | WO | disclosed |
| WO-2015066647-A9 | IONIC LIQUIDS FOR TRANSDERMAL DRUG DELIVERY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2015-09-17 | — | — | WO | disclosed |
| WO-2015066647-A2 | IONIC LIQUIDS FOR TRANSDERMAL DRUG DELIVERY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2015-05-07 | — | — | WO | disclosed |
| CN-104212849-A | Preparation method of lysophospholipids | SHAANXI SHENGMAI PETROLEUM CO | 2014-12-17 | — | — | CN | disclosed |
| CN-101827836-B | Trisubstituted 1,2, 4-triazole compounds | JANSSEN PHARMACEUTICA NV | 2014-02-19 | — | — | CN | disclosed |
| US-20120164072-A1 | NANO-SIZED PARTICLES COMPRISING MULTI-HEADED AMPHIPHILES FOR TARGETED DRUG DELIVERY | BEN-GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY (IL) | 2012-06-28 | — | — | US | disclosed |
| CN-102133351-B | Pharmaceutical composition for treating Alzheimer disease and preparation method thereof | PING FEI | 2012-05-09 | — | — | CN | disclosed |
| EP-2427175-A2 | NANO-SIZED PARTICLES COMPRISING MULTI-HEADED AMPHIPHILES FOR TARGETED DRUG DELIVERY | Ben-gurion University Of The Negev Research And Development Authority (IL) | 2012-03-14 | — | — | EP | disclosed |
| CN-102133351-A | Pharmaceutical composition for treating Alzheimer's disease and preparation method thereof | PING FEI | 2011-07-27 | — | — | CN | disclosed |
| WO-2010128504-A2 | NANO-SIZED PARTICLES COMPRISING MULTI-HEADED AMPHIPHILES FOR TARGETED DRUG DELIVERY | BEN-GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY (IL) | 2010-11-11 | — | — | WO | disclosed |
| CN-101827836-A | Trisubstituted 1,2, 4-triazole compounds | JANSSEN PHARMACEUTICA NV | 2010-09-08 | — | — | CN | disclosed |
| WO-2007079252-A2 | SUSTAINED RELEASE PHARMACEUTICAL COMPOSITIONS | AMPHASTAR PHARMACEUTICALS, INC. (US) | 2007-07-12 | — | — | WO | disclosed |
| US-20070154546-A1 | Sustained release pharmaceutical compositions | INTERNATIONAL MEDICATION SYSTEMS, LIMITED | 2007-07-05 | — | — | US | disclosed |
| CN-1455667-A | Use of aldosterone antagonists for the treatment or prevention of aldosterone-mediated pathogenic effects | PHARMACIA CORP (US) | 2003-11-12 | — | — | CN | disclosed |
| CN-1075885-C | Liquid projectile launcher | IUJECTION CO LTD (GB) | 2001-12-05 | — | — | CN | disclosed |
| CN-1282584-A | Application of icariin in preventing and treating sexual disfunction and improving diseases associated with vasoconstriction | XIN ZHONGCHENG (CN) | 2001-02-07 | — | — | CN | disclosed |
| EP-0206947-B1 | PHARMACEUTICAL COMPOSITION CONTAINING CHOLINE ESTER SALTS FOR ENHANCING GASTROINTESTINAL TRACT ABSORPTION | MERCK & CO. INC. (US) | 1992-04-15 | — | — | EP | disclosed |
| EP-0214898-B1 | CHOLINE ESTERS AS ABSORPTION-ENHANCING AGENTS FOR DRUG DELIVERY THROUGH MUCOUS MEMBRANES OF THE NASAL, BUCCAL, SUBLINGUAL AND VAGINAL CAVITIES | MERCK & CO. INC. (US) | 1992-03-11 | — | — | EP | disclosed |
| CN-1052142-A | Neurotrophic factor by the cerebral tissue acquisition | MAX PLANCK GESELLSCHAFT (DE) | 1991-06-12 | — | — | CN | disclosed |
| US-4973579-A | VIRICIDES | MERCK & CO., INC. (US) | 1990-11-27 | — | — | US | disclosed |
| US-4963556-A | ANTIVIRAL AGENTS | MERCK & CO., INC. (US) | 1990-10-16 | — | — | US | disclosed |
| US-4927728-A | Carrier particles for use in a two-component dry-type developer | RICOH COMPANY, LTD. (JP) | 1990-05-22 | — | — | US | disclosed |
| US-4835138-A | Choline esters as absorption-enhancing agents for drug delivery through mucous membranes of the nasal, buccal, sublingual and vaginal cavities | MERCK & CO., INC. (US) | 1989-05-30 | — | — | US | disclosed |
| US-4822773-A | Enhancement of absorption of drugs from gastrointestinal tract using choline ester salts | MERCK & CO., INC. (US) | 1989-04-18 | — | — | US | disclosed |
| US-4729989-A | Enhancement of absorption of drugs from gastrointestinal tract using choline ester salts | MERCK & CO., INC. (US) | 1988-03-08 | — | — | US | disclosed |
| US-4692441-A | B-LACTAM ANTIBIOTICS | MERCK & CO., INC. (US) | 1987-09-08 | — | — | US | disclosed |
| EP-0214898-A2 | Choline esters as absorption-enhancing agents for drug delivery through mucous membranes of the nasal, buccal, sublingual and vaginal cavities | MERCK & CO. INC. (US) | 1987-03-18 | — | — | EP | disclosed |
| EP-0206947-A2 | Pharmaceutical composition containing choline ester salts for enhancing gastrointestinal tract absorption | MERCK & CO. INC. (US) | 1986-12-30 | — | — | EP | disclosed |
| EP-0206947-A2 | Pharmaceutical composition containing choline ester salts for enhancing gastrointestinal tract absorption | MERCK & CO. INC. (US) | 1986-12-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (17 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170367980-A1 | NANO-SIZED PARTICLES COMPRISING MULTI-HEADED AMPHIPHILES FOR TARGETED DRUG DELIVERY | TSPO, ANXA6, ANXA11 | DGKA 1370/4885ADRA2A 3824/4885ADRA1A 2705/4885 |
| US-20120164072-A1 | NANO-SIZED PARTICLES COMPRISING MULTI-HEADED AMPHIPHILES FOR TARGETED DRUG DELIVERY | TSPO, ANXA6, ANXA11 | DGKA 1370/4885ADRA2A 3824/4885ADRA1A 2705/4885 |
| US-20230040805-A1 | IONIC LIQUIDS FOR INTERNAL DELIVERY | PNLIP, LIPA, CEL | DGKA 2641/4885ADRA2A 1985/4885ADRA1A 1506/4885 |
| US-20210162050-A1 | TOPICAL FORMULATIONS BASED ON IONIC SPECIES FOR SKIN TREATMENT | CUTA, KRT18, SLC38A7 | DGKA 1572/4885ADRA2A 4623/4885ADRA1A 4246/4885 |
| US-20190192661-A1 | TOPICAL FORMULATIONS BASED ON IONIC SPECIES FOR SKIN TREATMENT | CUTA, KRT18, SLC38A7 | DGKA 1572/4885ADRA2A 4623/4885ADRA1A 4246/4885 |
| US-20260115140-A1 | COMPOSITIONS FOR ENHANCED MUCOSAL PENETRATION | SLC10A2, SLC5A7, SLC18A3 | DGKA 3663/4885ADRA2A 619/4885ADRA1A 526/4885 |
| US-20070154546-A1 | Sustained release pharmaceutical compositions | PLA2G2C, PLTP, F12 | DGKA 3455/4885ADRA2A 2166/4885ADRA1A 2299/4885 |
| US-20210023009-A1 | NANO-SIZED PARTICLES COMPRISING MULTI-HEADED AMPHIPHILES FOR TARGETED DRUG DELIVERY | TSPO, ANXA6, ANXA11 | DGKA 1370/4885ADRA2A 3824/4885ADRA1A 2705/4885 |
| US-10842747-B2 | Nano-sized particles comprising multi-headed amphiphiles for targeted drug delivery | TSPO, ANXA6, ANXA11 | DGKA 1370/4885ADRA2A 3824/4885ADRA1A 2705/4885 |
| US-11446253-B2 | Ionic liquids for internal delivery | PNLIP, LIPA, CEL | DGKA 2641/4885ADRA2A 1985/4885ADRA1A 1506/4885 |
| US-10143969-B2 | Compounds for the capture of carbon dioxide from gaseous mixtures and subsequent release, related process and plant | GK, AGXT, GHDC | DGKA 371/4885ADRA2A 3172/4885ADRA1A 3024/4885 |
| US-20220257767-A1 | IONIC LIQUIDS FOR DRUG DELIVERY | SLCO4C1, SLC47A1, ABCB11 | DGKA 2906/4885ADRA2A 1699/4885ADRA1A 1627/4885 |
| US-20200289421-A1 | IONIC LIQUIDS FOR INTERNAL DELIVERY | PNLIP, LIPA, CEL | DGKA 2641/4885ADRA2A 1985/4885ADRA1A 1506/4885 |
| US-20260034075-A1 | CHOLINE CARBOXYLIC ACID BASED IONIC LIQUIDS AS ANTIMICROBIAL AGENTS | ELOVL3, L3MBTL3, ELOVL6 | DGKA 521/4885ADRA2A 2424/4885ADRA1A 3001/4885 |
| US-20230093875-A1 | IONIC LIQUIDS FOR INTERNAL DELIVERY | PNLIP, LIPA, CEL | DGKA 2641/4885ADRA2A 1985/4885ADRA1A 1506/4885 |
| US-20160346734-A1 | NOVEL COMPOUNDS FOR THE CAPTURE OF CARBON DIOXIDE FROM GASEOUS MIXTURES AND SUBSEQUENT RELEASE, RELATED PROCESS AND PLANT | GK, AGXT, GHDC | DGKA 340/4885ADRA2A 3117/4885ADRA1A 3017/4885 |
| US-10912834-B2 | Topical formulations based on ionic species for skin treatment | CUTA, KRT18, SLC38A7 | DGKA 1572/4885ADRA2A 4623/4885ADRA1A 4246/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.